The top 20 genes based on the gene frequency in the significantly activated cellular pathways between HER2+ and HER2− CRC patients showed key genes, including NKX2-5, NKX6-1, WNT3A, WNT5A, NOG, SOX9, SOX18 (Figure 5A). This evidence concerns the gene WNT3A and colorectal carcinoma.